BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Personalized medicine
,
Clofibrate
,
rs2230926
,
BRCA1
,
Lung cancer
,
Breast
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
zap 70 protein
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Chronic lymphocytic leukemia B cells marked with IgVH mutation (mutIgVH) and ZAP70 expression
B cell chronic lymphocytic leukemia cells compared based on miR-150 expression
Explore Curated Studies Results
Literature
Most Relevant Literature
Discovery and Structural Optimization of Covalent ZAP-70 Kinase Inhibitors against Psoriasis.
T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival.
T cell receptor-dependent S-acylation of ZAP-70 controls activation of T cells.
Discovery of a potent, selective, and covalent ZAP-70 kinase inhibitor.
A boy with a novel homozygous ZAP70 mutation presenting with a dermatological phenotype and postnata…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ex Vivo Effect of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage…
Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
A Study to Assess the Efficacy of Rituximab (MabThera) in First Line Treatment of Chronic Lymphocyti…
Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL)
Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed C…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ